US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 2.930
  • -0.090-2.98%
Close Mar 28 16:00 ET
  • 2.930
  • 0.0000.00%
Post 20:01 ET
250.59MMarket Cap-1.47P/E (TTM)

Atea Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
Net income from continuing operations
-23.85%-168.39M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
Depreciation and amortization
0.00%416K
0.00%104K
0.00%104K
0.00%104K
0.00%104K
60.00%416K
0.00%104K
-1.89%104K
141.86%104K
1,385.71%104K
Change In working capital
-146.25%-7.48M
-190.74%-8.54M
-121.08%-1.56M
-447.56%-11.48M
458.37%14.1M
134.69%16.16M
127.56%9.41M
133.07%7.38M
1,443.46%3.3M
86.25%-3.94M
-Change in prepaid assets
217.27%5.91M
43.69%-2.34M
-98.64%62K
461.72%3.12M
119.65%5.08M
129.82%1.86M
-135.37%-4.16M
161.19%4.57M
-131.74%-862K
740.36%2.31M
-Change in payables and accrued expense
-192.01%-13.22M
-147.32%-6.44M
-145.24%-1.29M
-472.35%-14.56M
250.97%9.07M
136.26%14.36M
366.39%13.61M
127.66%2.85M
216.97%3.91M
79.20%-6.01M
-Change in other current assets
--0
--287K
---287K
--0
--0
106.56%98K
--0
--0
--295K
---197K
-Change in other current liabilities
-8.70%-175K
-9.76%-45K
-7.50%-43K
-10.26%-43K
-7.32%-44K
-121.05%-161K
-17.14%-41K
0.00%-40K
-104.64%-39K
---41K
Cash from discontinued investing activities
Operating cash flow
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
Investing cash flow
Cash flow from continuing investing activities
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
Net investment purchase and sale
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.8M
108.89%40.3M
-17.07%27.77M
87.98%-58.51M
--46.57M
--24.48M
Cash from discontinued investing activities
Investing cash flow
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
Financing cash flow
Cash flow from continuing financing activities
3.89%267K
0
27.17%117K
0
-9.09%150K
-30.54%257K
0
-37.41%92K
0
-26.01%165K
Proceeds from stock option exercised by employees
3.89%267K
--0
27.17%117K
--0
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
Cash from discontinued financing activities
Financing cash flow
3.89%267K
--0
27.17%117K
--0
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
Net cash flow
Beginning cash position
-23.77%143.82M
-28.59%98.46M
13.79%243.39M
-12.29%160.91M
-23.77%143.82M
-75.33%188.66M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
Current changes in cash
-76.48%-79.13M
-668.76%-33.77M
-90.67%-144.93M
170.93%82.48M
428.28%17.09M
92.22%-44.84M
-50.29%5.94M
85.04%-76.01M
244.53%30.45M
91.15%-5.21M
End cash Position
-55.02%64.7M
-55.02%64.7M
-28.59%98.46M
13.79%243.39M
-12.29%160.91M
-23.77%143.82M
-23.77%143.82M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
Free cash flow
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
-33.55%-39.87M
30.53%-85.4M
-1.34%-21.83M
17.27%-17.59M
23.47%-16.12M
49.45%-29.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M-33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M
Net income from continuing operations -23.85%-168.39M14.35%-33.54M6.01%-31.15M-43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M
Depreciation and amortization 0.00%416K0.00%104K0.00%104K0.00%104K0.00%104K60.00%416K0.00%104K-1.89%104K141.86%104K1,385.71%104K
Change In working capital -146.25%-7.48M-190.74%-8.54M-121.08%-1.56M-447.56%-11.48M458.37%14.1M134.69%16.16M127.56%9.41M133.07%7.38M1,443.46%3.3M86.25%-3.94M
-Change in prepaid assets 217.27%5.91M43.69%-2.34M-98.64%62K461.72%3.12M119.65%5.08M129.82%1.86M-135.37%-4.16M161.19%4.57M-131.74%-862K740.36%2.31M
-Change in payables and accrued expense -192.01%-13.22M-147.32%-6.44M-145.24%-1.29M-472.35%-14.56M250.97%9.07M136.26%14.36M366.39%13.61M127.66%2.85M216.97%3.91M79.20%-6.01M
-Change in other current assets --0--287K---287K--0--0106.56%98K--0--0--295K---197K
-Change in other current liabilities -8.70%-175K-9.76%-45K-7.50%-43K-10.26%-43K-7.32%-44K-121.05%-161K-17.14%-41K0.00%-40K-104.64%-39K---41K
Cash from discontinued investing activities
Operating cash flow -58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M-33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M
Investing cash flow
Cash flow from continuing investing activities 39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M
Net investment purchase and sale 39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M132.03%56.8M108.89%40.3M-17.07%27.77M87.98%-58.51M--46.57M--24.48M
Cash from discontinued investing activities
Investing cash flow 39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M
Financing cash flow
Cash flow from continuing financing activities 3.89%267K027.17%117K0-9.09%150K-30.54%257K0-37.41%92K0-26.01%165K
Proceeds from stock option exercised by employees 3.89%267K--027.17%117K--0-9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K
Cash from discontinued financing activities
Financing cash flow 3.89%267K--027.17%117K--0-9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K
Net cash flow
Beginning cash position -23.77%143.82M-28.59%98.46M13.79%243.39M-12.29%160.91M-23.77%143.82M-75.33%188.66M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M
Current changes in cash -76.48%-79.13M-668.76%-33.77M-90.67%-144.93M170.93%82.48M428.28%17.09M92.22%-44.84M-50.29%5.94M85.04%-76.01M244.53%30.45M91.15%-5.21M
End cash Position -55.02%64.7M-55.02%64.7M-28.59%98.46M13.79%243.39M-12.29%160.91M-23.77%143.82M-23.77%143.82M-21.97%137.89M-68.76%213.9M-74.01%183.45M
Free cash flow -58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M-33.55%-39.87M30.53%-85.4M-1.34%-21.83M17.27%-17.59M23.47%-16.12M49.45%-29.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.